Join
Live feed
·
INSIDERFilingvia Quantisnow
Jounce Therapeutics Inc. logo

SEC Form 4: Trehu Elizabeth sold $10,316 worth of shares (9,285 units at $1.11), decreasing direct ownership by 8% to 103,417 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
JNCE· Jounce Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track JNCE (Jounce Therapeutics Inc.) and more on Quantisnow.